Validation in the BC-GSE42568 dataset confirmed consistent performance: BHLHE41 (0.7274), EPCAM (0.9610), ADH4 (0.6855), GSTM2 (0.7124), and GADD45G (0.6994) (Figure 5D). The gene discussed is GSTM2; the disease is breast cancer.